# OpenEvidence Raises $210M Series B at $3.5B Valuation

> financing · REPORTED · 2025-07-01

OpenEvidence raised a $210 million Series B funding round led by GV and Kleiner Perkins, valuing the AI clinical search engine at $3.5 billion and bringing total funding to over $300 million since its 2022 launch. The platform delivers synthesized, research-backed answers to clinician queries at the point of care and recently signed a content deal with JAMA Network.

About OpenEvidence: OpenEvidence is an AI-powered clinical decision support platform that provides physicians with instant, evidence-based answers synthesized from peer-reviewed medical literature, aiming to reduce physician burnout and improve point-of-care decision making.

- Company: OpenEvidence
- Sector: ai_healthcare
- Primary source: https://www.decibio.com/insights/digital-health-and-informatics-july-round-up-2025

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.